Good call on Letairis in IPH: Gilead Terminates Phase III Clinical Trial of Ambrisentan in Patients with Idiopathic Pulmonary Fibrosis http://finance.yahoo.com/news/Gilead-Terminates-Phase-III-bw-3130798699.html?x=0